Oncological Emergencies

Chapter 1 - Cardiac Complications of Cancer and Anti-Cancer Treatment

Brana I, Tabernero J. Cardiotoxicity. Ann Oncol 2010; 21(Suppl 7):vii173–vii179.

Curigliano G, Cardinale D, Suter T, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol 2012; 23(Suppl 7):vii155–vii166.

DeVita VT Jr, Lawrence TS, Rosenberg SA (Editors). DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology, 10th edition. Philadelphia: Lippincott-Raven, 2014.

Izzedine H, Ederhy S, Goldwasser F, et al. Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol 2009; 20:807–815.

Niederhuber JE, Armitage JO, Doroshow JH, et al (Editors). Abeloff’s Clinical Oncology, 5th edition. Philadelphia: Elsevier Churchill Livingstone, 2014.

Safra T. Cardiac safety of liposomal anthracyclines. Oncologist 2003; 8 Suppl 2:17–24.

Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339:900–905.

Todaro MC, Oreto L, Qamar R, et al. Cardioncology: state of the heart. Int J Cardiol 2013; 168:680–687.

Radiation Therapy-induced Cardiotoxicity Acknowledgements